TrialThe journal of headache and pain2018

Preventive effects of galcanezumab in adult patients with episodic or chronic migraine are persistent: data from the phase 3, randomized, double-blind, placebo-controlled EVOLVE-1, EVOLVE-2, and REGAIN studies.

Stefanie Förderreuther et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.